Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Homocysteine as a predictor of cognitive decline in Alzheimer's disease

Show other versions (1)

Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer�...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A
Outros Autores:	International College of Geriatric Psychoneuropharmacology
Formato:	Journal article
Idioma:	English
Publicado em:	John Wiley & Sons, Ltd. 2010
Assuntos:	Medical sciences Psychiatry

Registos relacionados

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Por: Oulhaj, A, et al.
Publicado em: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
Por: Smith, A, et al.
Publicado em: (2010)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
Por: de Jager, C, et al.
Publicado em: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
Por: De Jager, C, et al.
Publicado em: (2012)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
Por: Goodwin, G
Publicado em: (2003)

Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
Por: Goodwin, G
Publicado em: (2003)

Homocysteine, B vitamins, and cognitive impairment
Por: Smith, A, et al.
Publicado em: (2016)

Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people – Effects of sex and APOEe4
Por: Matteo Spinedi, et al.
Publicado em: (2024-02-01)

Homocysteine – A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
Por: Ines Elisabeth Futschek, et al.
Publicado em: (2023-02-01)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Por: Smith, A, et al.
Publicado em: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Por: Smith, A, et al.
Publicado em: (2010)

Homocysteine, B vitamins, and cardiovascular disease
Por: Refsum, H, et al.
Publicado em: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
Por: Refsum, H, et al.
Publicado em: (2006)

A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial)
Por: Ballard, C, et al.
Publicado em: (2008)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
Por: Oulhaj, A, et al.
Publicado em: (2016)

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Por: Martins, C, et al.
Publicado em: (2005)

Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism
Por: Fullerton, J, et al.
Publicado em: (2003)

High dimensional endophenotype ranking in the search for major depression risk genes
Por: Glahn, D, et al.
Publicado em: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
Por: De Jager, C, et al.
Publicado em: (2012)

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
Por: Clarke, R, et al.
Publicado em: (1998)

MET and autism susceptibility: family and case-control studies
Por: Sousa, I, et al.
Publicado em: (2009)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
Por: Jones, S, et al.
Publicado em: (2017)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
Por: A David Smith, et al.
Publicado em: (2010-09-01)

Investigating circadian disruption in mouse models of neurological and metabolic disorders
Por: Livieratos, A
Publicado em: (2013)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Por: Belbin, O, et al.
Publicado em: (2009)

How can magnetoencephalography and magnetic resonance imaging improve our understanding of genetic susceptibility to Alzheimer's disease?
Por: Heise, V
Publicado em: (2013)

Psychiatric, demographic and personality characteristics of elderly sex offenders
Por: Fazel, S, et al.
Publicado em: (2002)

Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
Por: Geetika Nehra, et al.
Publicado em: (2025-01-01)

The cognitive neuropsychology of depression in the elderly
Por: Herrmann, L, et al.
Publicado em: (2007)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
Por: Olivia M. Osborne, et al.
Publicado em: (2023-08-01)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
Por: Nurk, E, et al.
Publicado em: (2005)

Caregiver Burden is Associated with Cognitive Decline and Physical Disability of Elderly Post-Stroke Patients
Por: Othman, Zahiruddin, et al.
Publicado em: (2014)

Validation of the Malay Version of Short Informant Questionnaire on Cognitive Decline in the Elderly (MS-IQCODE)
Por: Othman, Zahiruddin, et al.
Publicado em: (2015)

Using neuroimaging and histology to understand hyperexcitability and atypical connectivity in autism spectrum disorder
Por: Ravishankar, M
Publicado em: (2015)

Effect of physical activity on anxiety and depression in COVID-19 adults: A systematic review and meta-analysis
Por: Qingyuan Luo, et al.
Publicado em: (2024-10-01)

QEEG in affective disorder: about to be a biomarker, endophenotype and predictor of treatment response
Por: Sermin Kesebir, et al.
Publicado em: (2018-08-01)

Alzheimer's Disease - A Comprehensive Review
Por: Kinga Woźniak, et al.
Publicado em: (2024-02-01)

Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study
Por: Luigi Zerbinati, et al.
Publicado em: (2022-10-01)

The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease
Por: Refsum, H, et al.
Publicado em: (2006)

Structural and functional magnetic resonance imaging (MRI) in the prediction and characterization of mild cognitive impairment (MCI) and Alzheimer's disease (AD)
Por: Zamboni, G
Publicado em: (2012)